Overall, local treatment of established gliomas with all IL-12 variants was associated with increased survival and pro-inflammatory lymphocyte polarization compared to untreated controls, with FcRn-silenced mIL-12hFc additionally exhibiting the highest frequency of durable clinical responses and lowest systemic exposure to IL-12. This evidence concerns the gene FCGRT and glioma.